SLL: Clinical Trials

3 trials for SLL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow SLL: new trials by email Literature Review of SLL trials Research Report on SLL

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
TP-0903, TP-0903 and ibrutinib combination therapy - Chronic Lymphocytic Leukemia, CLL
Phase 1 / Phase 2TerminatedSumitomo Pharma America, Inc.32019-06-102023-11-09
Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
A6 - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2TerminatedÃ…ngstrom Pharmaceuticals52014-02-012016-07-13
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab - CLL, SLL
Phase 2TerminatedDana-Farber Cancer Institute302011-12-012023-08-29

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, B-Cell (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Leukemia (1)  ·  Neoplasms (1)

Interventions

Alemtuzumab (1)  ·  Methylprednisolone (1)  ·  dubermatinib (1)  ·  ofatumumab (1)

Sponsors

Dana-Farber Cancer Institute (1)  ·  Sumitomo Pharma America, Inc. (1)  ·  Ã…ngstrom Pharmaceuticals (1)

Countries

United States (3)

Top investigators

Jennifer R Brown, MD PhD (1)  ·  Michael Choi, MD (1)  ·  Phillip Komarnitsky (1)

Results publications

PMID 30322319